NPPNY Projected Dividend Yield

ADR/Nippon Shinyaku Co Ltd ( OTCBB : NPPNY )

Nippon Shinyaku and its subsidiaries are mainly engaged in the research and development, manufacture, and sale of pharmaceuticals and functional food. Pharmaceuticals segment is engaged in the manufacture and sale of drugs for urological diseases, hematology, intractable and diseases, gynecology, allergies, cancer chronic pain, and other diseases under the names of "Zalutia," "Vidaza," "Uptravi," "Lunabel," "Erizas," and "Onetram." Functional Food segment is engaged in the manufacture and sale of health food ingredients, food preservatives, protein preparations, spices, and condiments for dietary supplements, meat processing, dairy products, confectionery, bakery, and beverages.

17 YEAR PERFORMANCE RESULTS